Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriele Picco

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Cancer Discovery|April 10, 2021
Werner Helicase Is a Synthetic-Lethal Vulnerability in Mismatch Repair-Deficient Colorectal Cancer Refractory to Targeted Therapies, Chemotherapy, and ImmunotherapyGabriele Picco, Chiara M Cattaneo, Esmée J van Vliet, et al.
Nature|April 12, 2019
Prioritization of cancer therapeutic targets using CRISPR-Cas9 screensFiona M Behan, Francesco Iorio, Gabriele Picco, et al.
Molecular Systems Biology|July 7, 2020
Drug mechanism-of-action discovery through the integration of pharmacological and CRISPR screensEmanuel Gonçalves, Aldo Segura-Cabrera, Clare Pacini, et al.
Cancer Discovery|April 8, 2024
Novel WRN Helicase Inhibitors Selectively Target Microsatellite-Unstable Cancer CellsGabriele Picco, Yanhua Rao, Angham Al Saedi, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Cancer Discovery|April 10, 2021
Werner Helicase Is a Synthetic-Lethal Vulnerability in Mismatch Repair-Deficient Colorectal Cancer Refractory to Targeted Therapies, Chemotherapy, and ImmunotherapyGabriele Picco, Chiara M Cattaneo, Esmée J van Vliet, et al.
Nature|April 12, 2019
Prioritization of cancer therapeutic targets using CRISPR-Cas9 screensFiona M Behan, Francesco Iorio, Gabriele Picco, et al.
Molecular Systems Biology|July 7, 2020
Drug mechanism-of-action discovery through the integration of pharmacological and CRISPR screensEmanuel Gonçalves, Aldo Segura-Cabrera, Clare Pacini, et al.
Cancer Discovery|April 8, 2024
Novel WRN Helicase Inhibitors Selectively Target Microsatellite-Unstable Cancer CellsGabriele Picco, Yanhua Rao, Angham Al Saedi, et al.
Pageof 3